Clin2
NCT07136766Possibly a fitEnrolling by invitation

Test cream vs prescription cream for dark spots on face

Hyperpigmentation

Part of Skin clinical trials.

This study tests a new cream against a standard prescription cream (4% hydroquinone) to treat dark spots or melasma on the face. You will use a cream daily and avoid other skin treatments for about 4 months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
40 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have dark patches or melasma on your face.
  • You are willing to use a prescription-strength lightening cream (4% hydroquinone) for up to 10 weeks.
  • You will stop using any other skin-lightening products or treatments (like peels or facials) during the study.
  • You can receive emails on your phone to complete forms and questionnaires.
  • You agree to be photographed and sign a release form.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06268496Recruiting
Study of a cream for facial dark spots

This trial tests a skincare formula for treating three types of dark spots on the face: melasma, acne marks, and age spots. It aims to see if the product is effective and gentle after 3 months of daily use.

Osasco
NCT06253468Recruiting
A cream for dark spots from sun, melasma, or acne

This study tests a new cream for facial dark spots caused by sun damage, melasma, or acne. It aims to see if the cream is safe and effective over three months.

Singapore
NCT07769268Recruiting
Cream for treating dark spots on the face

This study tests a cosmetic cream to reduce dark spots on the face, including melasma and sun spots. It aims to see if the product improves the appearance of hyperpigmentation.

Osasco, São Paulo
NCT07429786Not yet recruiting
MelaB3 serum and glycolic acid peel for skin dark spots

This trial tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for treating dark spots caused by melasma, acne scars, or sun damage. It may be a good option if you have mild to moderate dark spots and are willing to avoid sun exposure and other skin-lightening products.

NCT07071363Recruiting
Serum vs hydroquinone for melasma treatment

This trial compares a new cosmetic serum to a standard treatment (4% hydroquinone) for facial melasma over 84 days. It may help if you have mild to moderate melasma and are looking for a gentler alternative.

Port Louis, Phoenix
NCT07679945Recruiting
Study of facial sunscreen for dark spots

This study tests whether a facial sunscreen can reduce dark spots and pigmentation after 8 weeks of daily use. It may be a good option if you have age spots, melasma, or other dark marks on your face and want a simple, non-invasive treatment.

Campinas, São Paulo

Hear when a new Hyperpigmentation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.